In the BioHarmony Drug Report Database
Captopril
Capoten (captopril) is a small molecule pharmaceutical. Captopril was first approved as Capoten on 1982-01-01. It is used to treat bartter syndrome, diabetic nephropathies, edema, heart failure, and left ventricular dysfunction amongst others in the USA. The pharmaceutical is active against angiotensin-converting enzyme. In addition, it is known to target angiotensin converting enzyme.
Trade Name
|
Capoten |
|---|---|
Common Name
|
captopril |
ChEMBL ID
|
CHEMBL1560 |
Indication
|
bartter syndrome, diabetic nephropathies, edema, heart failure, left ventricular dysfunction, malignant hypertension, raynaud disease, rheumatoid arthritis |
Drug Class
|
Aptamers, classical and mirror; antihypertensives (ACE inhibitors) |
Image (chem structure or protein)